Seattle biotech Omeros selling drug franchise in deal valued at over $1B

The deal includes a $125 million upfront payment and a commercial milestone payment of $200 million for Omidria, a drug used in cataract surgery.

Source: bizjournals.com Health Care:Physician Practices headlines - December 3, 2021 Category: American Health Authors: Rick Morgan Source Type: news